In a nutshell, imposter syndrome is the overwhelming belief that you’re a fraud, despite objective evidence to the contrary, and it’s rare for any physician to be completely immune. This pattern of thinking can cause pervasive anxiety, frequently contributing to physician burnout. Here are three tips to help overcome these feelings and take positive steps toward building back your self-worth.

In this article from the Journal of Clinical Oncology, the authors suggest the need for caution and well-conducted trials to systematically address the question of total neoadjuvant therapy (TNT) in rectal cancer, which can lead to overtreatment and unnecessary toxicity without a proven benefit. Despite some of its theoretical advantages, declaring TNT a new standard of care may be premature.

In this podcast/article from KevinMD.com, the author questions how FIGS – a design-driven medical apparel company – let a flagrantly offensive advertisement against DOs get published, in addition to other criticism: “We should also ponder how – despite 150 years of DO education within the US – we’ve failed to correct the systemic discrimination against osteopathic students and physicians.”

Medical practices incorporate digital apps to improve online scheduling, send appointment reminders, and provide telemedicine options. And physicians now have entire medical libraries at their fingertips to confirm a diagnosis, check drug interactions, and collaborate with other HCPs. Here are some of the most popular medical apps for doctors, nurses, and medical students.

To help ready physicians with sound, scientific knowledge—untarnished by political views—essential to combating COVID-19, the Annals of Internal Medicine and the American College of Physicians hosted the COVID-19 Vaccine Forum on 10/16/20 to offer current, evidence-based information related to the science, approval processes, and development of clinical recommendations for vaccines.

In the past decade, several promising immunotherapies have been developed, changing the treatment landscape for children with relapsed acute lymphoblastic leukemia (ALL). These advances in treatment offer real promise for less toxic and more effective therapy for children. In this article from Blood, the authors present several cases highlighting contemporary treatment decision-making.